Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIO-MEDICAL CONSULT HOLDING ApS
APS
Active
CVR 32260519
M.A. Schultz Vej 7
Activities of holding companies · NACE 6421
Est. 2009
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK -27K
-29% vs 2024
EBITDA margin
100.0%
+29% vs 2024
Equity ratio
79.2%
Financial strength
Net profit 2025
DKK 627K
-65% vs 2024
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
DKK -27K
-29%
EBITDA
DKK -27K
+29%
Net profit
DKK 627K
-65%
Total assets
DKK 23,4M
+5%
Equity
DKK 18,5M
+4%
Employees
—
—
Company information
Legal name
BIO-MEDICAL CONSULT HOLDING ApS
CVR number
32260519
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
11. juni 2009
Share capital
DKK 152.450
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at være holdingselskab samt varetage formueforvaltning og anden investeringsvirksomhed.
Contact
Address
M.A. Schultz Vej 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Activities of holding companies
Companies in Aalborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
-24
-18
-21
-39
-27
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-24
-18
-21
-39
-27
Depreciation & amort.
-71
-48
-2
-2
-2
EBIT
-95
-67
-23
-41
-29
Net financials
585
-1.733
1.385
1.852
882
Profit before tax
490
-1.800
1.362
1.811
852
Tax
92
-53
-28
7
225
Net profit
398
-1.747
1.391
1.804
627
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
19.075
17.931
19.335
22.376
23.385
Equity
16.592
14.845
16.236
17.890
18.518
Long-term debt
0
0
0
0
0
Short-term debt
2.423
3.085
3.099
4.486
4.790
Total debt
2.423
3.085
3.099
4.486
4.790
Financial ratios
5-year trend
EBITDA margin
-2742700.0%
This company
15.8%
Market median
-17358961% vs market
2021
2025
Equity ratio
79.2%
This company
38.2%
Market median
+107% vs market
2021
2025
Return on equity
3.4%
This company
18.4%
Market median
-82% vs market
2021
2025
Net profit margin
62747000.0%
This company
8.1%
Market median
+774654221% vs market
2021
2025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Lars Arendt-Nielsen
Individual
90–99.99%
90–99.99%
2009
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
BIO-MEDICAL CONSULT HOLDING ApS
(this company)
C4PAIN ApS
Board network connections
Board members of BIO-MEDICAL CONSULT HOLDING ApS also hold positions in
0
other companies.
Person
Role here
Other companies